- Visibility 29 Views
- Downloads 28 Downloads
- Permissions
- DOI 10.18231/j.ijca.10439.1759905202
-
CrossMark
Comparing the efficacy of ondansetron vs palonosetron in the prevention of shivering under spinal anaesthesia in patients undergoing transurethral resection of the prostate
- Author Details:
-
Renganathan Sockalingam *
-
Indumathy Seeralan
-
Pavala Kannan Velu
-
Ganesh Prabhu S C
Renganathan Sockalingam *
Indumathy Seeralan
Pavala Kannan Velu
Ganesh Prabhu S C
Background: Shivering is a common postanaesthetic complication that causes metabolic stress and discomfort. Pharmacological management includes 5-HT3 receptor antagonists, such as ondansetron and palonosetron; however, their comparative efficacy is unclear. This study compared the efficacy of ondansetron and palonosetron in preventing postanaesthetic shivering (PAS) in patients undergoing transurethral resection of the prostate (TURP) under spinal anaesthesia.
Materials and Methods: This prospective, double-blind, randomised study involved patients assigned to Group A (ondansetron 8 mg IV) or Group B (palonosetron 0.075 mg IV) 30 min before surgery. A standardised spinal anaesthesia protocol used 0.5% bupivacaine. Patients were monitored for temperature, haemodynamic parameters, and PAS severity at multiple time points up to 120 min postoperatively. The incidence of shivering, vomiting, and temperature variations was assessed and managed.
Results: The incidence of shivering was lower with palonosetron (7.8%) than with ondansetron (21.1%) (p=0.011). Vomiting was lower in the palonosetron group (6.7%) versus ondansetron (13.3%) (p=0.136). At 120 minutes postoperatively, 91.6% had temperatures ≥36°C, 1.7% were 35.5–35.9°C, 5% were 35.0–35.4°C, and 1.7% <35.0°C. Patients with shivering had higher systolic (144.0 ± 6.1 mmHg) and diastolic (95.0 ± 4.9 mmHg) blood pressures at 120 minutes than non-shivering patients (119.0 ± 5.4 mmHg, 83.2 ± 4.2 mmHg, p<0.001). Younger patients (57.0 ± 11.3 years) were more prone to shivering than older ones (62.2 ± 11.8 years, p=0.027).
Conclusion: Palonosetron is more effective than ondansetron in preventing PAS, with a lower incidence of shivering and vomiting. Further studies with larger cohorts are required to validate these findings.